Delavirdine approved for use in treating HIV.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D020008:Delavirdine; D017277:Drug Approval; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D007211:Indoles; D010879:Piperazines; D018894:Reverse Transcriptase Inhibitors; D020008:Delavirdine